滤泡性甲状腺癌巨滤泡变异型:甲状腺癌诊断中罕见且被低估的陷阱
本文描述4例包裹性滤泡性肿瘤,组织学以巨滤泡结构为主(>70%)但伴包膜侵犯,分类为巨滤泡变异型滤泡性甲状腺癌(MV-FTC)。细胞学上3/4例FNAC诊断为良性,因结节增大行甲状腺切除;组织学示局灶局限包膜侵犯无血管侵犯,二代测序发现7个体细胞变异包括2例DICER1双突变,临床结局均良好,提示MV-FTC行为惰性但FNAC假阴性率高且极罕见(<0.05%甲状腺切除标本)。
要点
- 巨滤泡结构为主且无PTC核特征的甲状腺结节FNAC常判良性,但需警惕MV-FTC可能。
- MV-FTC组织学表现为包膜侵犯而无血管侵犯,临床行为类似微小浸润性滤泡癌,结局良好。
- MV-FTC极罕见(<0.05%甲状腺切除标本),FNAC假阴性率高,需更大样本研究阐明生物学行为。
核心结论
- MV-FTC行为惰性,类似经典微小浸润性滤泡性甲状腺癌,但FNAC假阴性率高且极罕见(<0.05%甲状腺切除标本)。
研究设计与样本
- 描述4例组织学以巨滤泡结构为主(>70%)且伴包膜侵犯的包裹性滤泡性肿瘤的临床、细胞学、组织学和分子遗传学特征。
- 对每例肿瘤与匹配正常DNA行二代测序(定制394基因面板)。
主要发现
- 细胞学上所有病例均见巨滤泡结构,4例中3例FNAC诊断为良性。
- 因结节增大所有病例行甲状腺切除,组织学示局灶局限包膜侵犯,无血管侵犯。
- 二代测序共发现7个体细胞变异,包括2例患者DICER1基因双突变(可能双等位)。
- 所有病例临床结局良好。
关键数值与推荐
- MV-FTC组织学定义:包裹性滤泡性肿瘤以巨滤泡结构为主(>70%)并伴包膜侵犯。
- MV-FTC占所有甲状腺切除标本<0.05%。
- 细胞学见巨滤泡结构且无PTC相关核特征时FNAC常判良性,但本组4例中3例FNAC假阴性。
临床怎么用
- 对巨滤泡结构为主、FNAC良性的甲状腺结节,若结节增大应考虑手术切除以除外MV-FTC。
- 术后组织学需仔细评估包膜侵犯以识别MV-FTC,避免漏诊。
局限性
- 仅4例病例,样本量小。
- 需更大系列研究进一步阐明MV-FTC的生物学行为。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Follicular-patterned thyroid nodules predominantly composed of macrofollicular structures without nuclear atypia are generally regarded as benign (i.e., hyperplastic nodules or follicular adenomas). In line with this concept, fine-needle aspiration cytology (FNAC) also assigns a benign connotation to the presence of macrofollicular structures, unless thyrocytes present papillary thyroid carcinoma (PTC)-related nuclear features that raise the possibility of a macrofollicular variant of PTC. However, cases showing macrofollicular architecture, capsular invasion, and no PTC features can also be observed. Methods: We describe the clinical, cytological, histological, and molecular genetic features of four cases of encapsulated follicular neoplasms that presented histologically with a predominant (>70%) macrofollicular architecture, but which also showed clear signs of capsular invasion, and thus were classified as macrofollicular variant of follicular thyroid carcinoma (MV-FTC). Results: Cytologically, macrofollicular structures were identified in all cases, leading to a benign FNAC diagnosis in three of the four cases. Due to increasing nodule size, thyroidectomy was performed in all cases. Histology showed focal and limited capsular invasion, without vascular invasion. Next-generation sequencing (custom 394 gene panel) of each tumor compared with matched normal DNA revealed a total of 7 somatic variants, including dual (likely biallelic) mutations in the DICER1 gene in 2 patients. The clinical outcome was excellent in all cases. Conclusions: Similar to the classical minimally invasive follicular thyroid carcinoma, MV-FTC appears to behave indolently. MV-FTC has a high rate of false-negative FNAC results, but MV-FTC is very rare (<0.05% of all thyroidectomies) and apparently has an indolent behavior. Further studies comprising larger series are necessary to better clarify the biology of this diagnostically challenging rare tumor.
引用
- Bongiovanni M, Sykiotis GP, La Rosa S, et al. Macrofollicular Variant of Follicular Thyroid Carcinoma: A Rare Underappreciated Pitfall in the Diagnosis of Thyroid Carcinoma. Thyroid. 2019. PMID: 31701808. doi:10.1089/thy.2018.0607
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。